Skip to content

Prednisolone on pregnancy outcomes

Effects of Prednisolone on pregnancy outcomes among infertile patients undergoing ??Intra Cytoplasmic Sperm Injection (ICSI)?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014111213421N2
Enrollment
248
Registered
2015-01-10
Start date
2010-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female infertility, unspecified

Interventions

Intervention 1: Control group: Patients who candidate for microinjection (ICSI), underwent for induction of ovulation, underwent by long protocol in the beginning of cycle. Determination of uterus dep
Colorado, USA) was used for all embryo culturing. Embryo scoring was done according to zonal thickness, cytoplasm fragmentation, blastomeres number, and morphology. The clinician also made sure that t
Treatment - Drugs
Control group: Patients who candidate for microinjection (ICSI), underwent for induction of ovulation, underwent by long protocol in the beginning of cycle. Determination of uterus depth was done for
Intervention Group also followed the same procedure as control groups and the same medications were used. In addition, 20 mg daily prednisolone was given to all Intervention Group, One day before the

Sponsors

Urmia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: i nclusion criteria: having infertility;FSH serum levels lower than 10 ,age of lower than 42 years exclusion criteria: having asthma; systemic disorders; gastrointestinal disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Abortion. Timepoint: until 20 weeks. Method of measurement: observation.;Intra uterus pregnancy. Timepoint: 12,20 weeks. Method of measurement: sonography.;Chemical pregnancy. Timepoint: 6 weeks. Method of measurement: BHCG mesuring.

Secondary

MeasureTime frame
None. Timepoint: none. Method of measurement: none.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Nanbakhsh

Reproductive Health Research Center

-+98 44 3344 5138

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026